newsfilter
← Latest News
Business Wire·

Longboard Pharmaceuticals to Participate in Four Upcoming Investor Conferences in September

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that members of its leadership